427 PARK ST., CHARLOTTESVILLE, VA
Reports Second Quarter 2026 Financial Results and Business Highlights
Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
Financial Results, Reg. FD
Annual Report to Security Holders
Investor Presentation
Reports Third Quarter 2025 Financial Results and Business Highlights
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
SEC Staff Correspondence
S-1MEF